Zephyrnet Logo

Tag: liver disease

Elevate Your Sleep Game This World Health Day with LAC

SINGAPORE, Apr 25, 2024 - (ACN Newswire) - Despite the well-known importance of sleep for physical and mental well-being, a significant portion of Singaporeans find...

Top News

Boosting curcumin’s absorption and effectiveness for disease prevention and therapy

In a recent review published in the journal Antioxidants, researchers explored the potential of nano-formulations to boost the bioavailability and bioactivity of curcumin and...

Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases – Nature Nanotechnology

Klotter, V. et al. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: results from a prospective longitudinal cohort study. PLoS...

CBD 101: Exploring Various Types Of CBD & Their Uses – Free CBD Buyers Guide, Local Directory, CBD Calculator, & More

Understanding The Different Types Of CBD Products Cannabidiol, commonly known as CBD, has surged in popularity over recent years, becoming a staple in wellness and...

Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure |...

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION23 January 2024, 07:00 am CET DSMBi rates DSR 2.0 as safe following review of data from non-randomized cohort Data from...

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis | BioSpace

REGULATED INFORMATION – INSIDE INFORMATION Pending FDA approval, alfapump could become the first active implantable medical device in the US for treating liver ascites Ghent,...

After Weight Loss, Ozempic Is Set to Conquer a Universe of Brain Disorders

One inescapable word dominated biomedicine this year: Ozempic.Physicians were amazed at the drug’s efficacy in treating diabetes, for which it is FDA approved, and...

Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission | BioSpace

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION19 October 2023, 07:00 am CEST One-year alfapump data from POSEIDON shows safety and strong efficacy profile is...

Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious...

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION18 October 2023, 07:00 am CEST First two US patients from non-randomized cohort successfully treated with DSR 2.0...

Scientists Unearth Brand New Links Between Genes and Disease in Our Blood

A blood draw is one the most mundane clinical tests. It’s can also be a Rosetta stone for decoding genetic information and linking DNA...

Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours – Nature Nanotechnology

Dewhirst, M. W. & Secomb, T. W. Transport of drugs from blood vessels to tumour tissue. Nat. Rev. Cancer 17, 738–750 (2017).Article  CAS  ...

Sequana Medical Notice of 2023 Half-year Results and Business Update | BioSpace

Ghent, Belgium – 6September2023– Sequana Medical NV(Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of fluid overload in liver disease,...

What is primary sclerosing cholangitis (PSC)?

Primary sclerosing cholangitis (PSC) is a condition that impacts the bile ducts of the liver, causing them to become inflamed and ultimately scar. It...

Latest Intelligence

spot_img
spot_img